review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Vassilios Papalois | |
Karim Hamaoui | |||
P2860 | cites work | Hypothermic Oxygenated Machine Perfusion of the Human Donor Pancreas | Q93379886 |
Advances in machine perfusion graft viability assessment in kidney, liver, pancreas, lung, and heart transplant | Q27003239 | ||
Pancreas transplantation | Q30234963 | ||
Outcome of pancreas transplantation from donation after circulatory death compared to donation after brain death. | Q30241373 | ||
OPTN/SRTR 2015 Annual Data Report: Pancreas | Q31152694 | ||
Organ assessment and repair centers: The future of transplantation is near | Q33891740 | ||
Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy | Q34231811 | ||
Transplantation for the treatment of type 1 diabetes | Q34382898 | ||
Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. | Q36014104 | ||
Pancreas transplantation: 50 years of experience | Q36396295 | ||
The long-term management of pancreas transplantation | Q36632969 | ||
Can 'extreme' pancreas donors expand the donor pool? | Q37228272 | ||
Long-term benefits of pancreas transplantation | Q37228284 | ||
Ischemia and reperfusion--from mechanism to translation | Q37455225 | ||
Protocol of a randomised controlled, open-label trial of ex vivo normothermic perfusion versus static cold storage in donation after circulatory death renal transplantation | Q37612112 | ||
Machine perfusion or cold storage in organ transplantation: indication, mechanisms, and future perspectives | Q37674852 | ||
Towards graft-specific immune suppression: Gene therapy of the transplanted kidney | Q37778117 | ||
Preservation strategies to reduce ischemic injury in kidney transplantation: pharmacological and genetic approaches | Q37854401 | ||
Hypothermic reconditioning in organ transplantation | Q38073548 | ||
APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model | Q38411332 | ||
Utilization of organs from donors after circulatory death for vascularized pancreas and islet of Langerhans transplantation: recommendations from an expert group | Q38580738 | ||
Long-term diabetes complications after pancreas transplantation | Q38734106 | ||
Pancreas transplantation: a decade of decline | Q38812721 | ||
Ex Vivo Porcine Organ Perfusion Models as a Suitable Platform for Translational Transplant Research | Q39165112 | ||
Organ Pretreatment With Cytotopic Endothelial Localizing Peptides to Ameliorate Microvascular Thrombosis and Perfusion Deficits in Ex Vivo Renal Hemoreperfusion Models. | Q39176260 | ||
Donors after circulatory death pancreas transplantation. | Q39415099 | ||
Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial. | Q42841256 | ||
Hypothermic reconditioning after cold storage improves postischemic graft function in isolated porcine kidneys | Q43232906 | ||
Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. | Q44077824 | ||
A method for the mass isolation of islets from the adult pig pancreas | Q44192834 | ||
Machine perfusion or cold storage in deceased-donor kidney transplantation | Q46178071 | ||
Influence of oxygen concentration during hypothermic machine perfusion on porcine kidneys from donation after circulatory death | Q46818174 | ||
Hypothermic Machine Perfusion in Liver Transplantation | Q47172990 | ||
Normothermic machine perfusion for the assessment and transplantation of declined human kidneys from donation after circulatory death donors | Q47174708 | ||
Mesenchymal Stromal Cells as Anti-Inflammatory and Regenerative Mediators for Donor Kidneys During Normothermic Machine Perfusion. | Q47209843 | ||
Reconditioning by end-ischemic hypothermic in-house machine perfusion: A promising strategy to improve outcome in expanded criteria donors kidney transplantation. | Q47246992 | ||
The effect of machine perfusion on the arteries of porcine kidneys. | Q47353201 | ||
Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: a UK multicenter randomized controlled trial. | Q47411717 | ||
Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story | Q47573600 | ||
Hypothermic machine preservation in human liver transplantation: the first clinical series. | Q47582231 | ||
Pancreas Transplantation: An Alarming Crisis in Confidence | Q48220347 | ||
High temporal resolution delayed analysis of clinical microdialysate streams. | Q49754580 | ||
Development of pancreatic machine perfusion: translational steps from porcine to human models | Q50080750 | ||
Use of Ex Vivo Normothermic Perfusion for Quality Assessment of Discarded Human Donor Pancreases. | Q50445105 | ||
Hypothermic pulsatile perfusion of human pancreas: Preliminary technical feasibility study based on histology | Q57186333 | ||
Perfusion of Porcine Kidneys with Macromolecular Heparin Reduces Early Ischemia Reperfusion Injury | Q57297200 | ||
HS supplementation: A novel method for successful organ preservation at subnormothermic temperatures | Q58561511 | ||
Vulnerability of Islets in the Immediate Posttransplantation Period: Dynamic Changes in Structure and Function | Q60192419 | ||
Solid pancreas transplant: Pushing forward | Q60310426 | ||
The Benefits of Hypothermic Machine Preservation and Short Cold Ischemia Times in Deceased Donor Kidneys | Q60400311 | ||
Oxygenated Kidney Preservation Techniques | Q61784337 | ||
Pancreaticoduodenal Preservation by Hypothermic Pulsatile Perfusion for Twenty-four Hours | Q66902275 | ||
Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group | Q68499210 | ||
Pretransplant Kidney-Specific Treatment to Eliminate the Need for Systemic Immunosuppression | Q82452421 | ||
Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization | Q82732678 | ||
Machine perfusion or cold storage in deceased-donor kidney transplantation | Q83490095 | ||
Machine perfusion and long-term kidney transplant recipient outcomes across allograft risk strata | Q87861404 | ||
Normothermic Ex Vivo Perfusion of Discarded Human Pancreas | Q87998815 | ||
A Study of Normothermic Hemoperfusion of the Porcine Pancreas and Kidney | Q88380873 | ||
Evolution of Deceased Organ Donation Activity Versus Efficiency Over a 15-year Period: An International Comparison | Q88421377 | ||
Ex vivo normothermic porcine pancreas: A physiological model for preservation and transplant study | Q88578693 | ||
Maximizing Utilization in Pancreas Transplantation: Phenotypic Characteristics Differentiating Aggressive From Nonaggressive Transplant Centers | Q89259078 | ||
Gene Silencing With siRNA (RNA Interference): A New Therapeutic Option During Ex Vivo Machine Liver Perfusion Preservation | Q90612071 | ||
The survival advantage of pancreas after kidney transplant | Q91315333 | ||
OPTN/SRTR 2017 Annual Data Report: Pancreas | Q91967809 | ||
Navigating Two Roads to Glucose Normalization in Diabetes: Automated Insulin Delivery Devices and Cell Therapy | Q92168760 | ||
First Report of siRNA Uptake (for RNA Interference) During Ex Vivo Hypothermic and Normothermic Liver Machine Perfusion | Q93001992 | ||
A steady decline in pancreas transplantation rates | Q93192204 | ||
P433 | issue | 8 | |
P304 | page(s) | 56 | |
P577 | publication date | 2019-07-10 | |
P1433 | published in | Current diabetes report | Q26841965 |
P1476 | title | Machine Perfusion and the Pancreas: Will It Increase the Donor Pool? | |
P478 | volume | 19 |
Q102328555 | Development and validation of a quantitative electron microscopy score to assess acute cellular stress in the human exocrine pancreas |
Q95334561 | Reasons for Low Utilization of Pancreas for Transplantation From Deceased Donors: Analysis of Data From a Single Center in India |
Q90041318 | The Effect of Preservation Temperature on Liver, Kidney, and Pancreas Tissue ATP in Animal and Preclinical Human Models |
Search more.